Literature DB >> 18582969

The Syntax score predicts peri-procedural myocardial necrosis during percutaneous coronary intervention.

William J van Gaal1, Francis A Ponnuthurai, Joseph Selvanayagam, Luca Testa, Italo Porto, Stefan Neubauer, Adrian P Banning.   

Abstract

BACKGROUND: Peri-procedural myocardial injury (PPI) during percutaneous coronary intervention (PCI) is common and associated with a poor outcome. No reliable angiographic or clinical predictors of PPI exist. We evaluated the ability of the SYNTAX score (SXscore), Gensini score, American Heart Association/American College of Cardiology (AHA/ACC) and Society for Cardiovascular Angiography and Intervention (SCAI) classifications to predict PPI.
METHODS: Consecutive patients were included from two existing databases of PCI. Patients with coronary bypass grafts or instent restenosis were excluded. PPI was defined as troponin I elevation (>1.0 microg/L) at 6-24 h post-PCI. Delayed enhancement magnetic resonance imaging distinguished PPI territory in patients undergoing multi-vessel PCI. Quantitative coronary angiography was performed blinded to PPI. In total, 100 patients underwent PCI to 122 vessels. PPI occurred in 20/100 (20.0%) patients.
RESULTS: Mean patient SXscore was higher in patients with PPI (20.6 vs. 12.4, p = 0.0001), however Gensini score was not significantly different (34.2 vs. 27.3, p = 0.15). Mean vessel SXscore was higher in vessels associated with PPI (12.1 vs. 7.6, p = 0.002), but not different for vessel Gensini score (16.2 vs. 13.6, p = 0.42). No vessels with AHA type A or B1 lesions were associated with PPI. Higher AHA scores (B2 and C) were associated with PPI (chi2 for trend 11.6, p = 0.0007). SCAI scores were not predictive of PPI (chi2 for trend 3.6, p = 0.06). By ROC analysis, a patient SXscore of > or = 17 predicted PPI with a sensitivity of 75.0% and specificity of 70.0%.
CONCLUSION: Higher SXscores are predictive of myocardial injury, whilst AHA type A and B1 lesions have a high negative predictive value for PPI.

Entities:  

Mesh:

Year:  2008        PMID: 18582969     DOI: 10.1016/j.ijcard.2008.03.033

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  31 in total

Review 1.  Nanoscale science: a big step towards the Holy Grail of single molecule biochemistry and molecular biology.

Authors:  R C Doty; D G Fernig; R Lévy
Journal:  Cell Mol Life Sci       Date:  2004-08       Impact factor: 9.261

2.  Incidence of periprocedural myocardial infarction and cardiac biomarker testing after percutaneous coronary intervention in Japan: results from a multicenter registry.

Authors:  Takahide Arai; Shinsuke Yuasa; Hiroaki Miyata; Akio Kawamura; Yuichiro Maekawa; Shiro Ishikawa; Shigetaka Noma; Soushin Inoue; Yuji Sato; Shun Kohsaka; Keiichi Fukuda
Journal:  Heart Vessels       Date:  2012-12-29       Impact factor: 2.037

3.  Correlation of NLRP3 with severity and prognosis of coronary atherosclerosis in acute coronary syndrome patients.

Authors:  Altaf Afrasyab; Peng Qu; Yang Zhao; Kuang Peng; Hongyan Wang; Dayuan Lou; Nan Niu; Dajun Yuan
Journal:  Heart Vessels       Date:  2015-08-20       Impact factor: 2.037

4.  Terminal QRS distortion and severity of coronary artery disease in ST-elevation myocardial infarction.

Authors:  E M Bakirci; K Kalkan; H Hamur; M Buyuklu; M Cetin; H Degirmenci; H Duman; Z Kucuksu; I H Tanboga; E Topal
Journal:  Herz       Date:  2014-01-19       Impact factor: 1.443

5.  Relationship between C-reactive protein/albumin ratio and coronary artery disease severity in patients with stable angina pectoris.

Authors:  Yavuz Karabağ; Metin Çağdaş; Ibrahim Rencuzogullari; Süleyman Karakoyun; İnanç Artaç; Doğan İliş; Eray Atalay; Mahmut Yesin; Mustafa Ozan Gürsoy; Ibrahim Halil Tanboğa
Journal:  J Clin Lab Anal       Date:  2018-04-18       Impact factor: 2.352

6.  The Effect of High Dose Cilostazol and Rosuvastatin on Periprocedural Myocardial Injury in Patients with Elective Percutaneous Coronary Intervention.

Authors:  Ari H; Emlek N; Ari S; Coşar S; Doğanay K; Aydin C; Tenekecioğlu E; Tütüncü A; Yontar O C; Gürdoğan M; Bozat T; Melek M
Journal:  Acta Cardiol Sin       Date:  2015-07       Impact factor: 2.672

7.  Comparison between Exclusive and Selective Drug-Eluting Stent Strategies in Treating Patients with Multivessel Coronary Artery Disease.

Authors:  Ying-Chang Tung; Ping-Gune Hsiao; Lung-An Hsu; Chi-Tai Kuo; Chi-Jen Chang
Journal:  Acta Cardiol Sin       Date:  2014-05       Impact factor: 2.672

8.  Aortic valve sclerosis in acute coronary syndrome patients : potential value in predicting coronary artery lesion complexity.

Authors:  L Korkmaz; E Pelit; H Bektas; M T Ağaç; H Erkan; I Gurbak; Ş Çelik
Journal:  Herz       Date:  2013-09-27       Impact factor: 1.443

9.  Consideration of a new definition of clinically relevant myocardial infarction after coronary revascularization: an expert consensus document from the Society for Cardiovascular Angiography and Interventions (SCAI).

Authors:  Issam D Moussa; Lloyd W Klein; Binita Shah; Roxana Mehran; Michael J Mack; Emmanouil S Brilakis; John P Reilly; Gilbert Zoghbi; Elizabeth Holper; Gregg W Stone
Journal:  J Am Coll Cardiol       Date:  2013-10-22       Impact factor: 24.094

10.  Serum total bilirubin levels and disease severity in patients with stable coronary artery disease.

Authors:  J Yu; J-L Han; G-S Wang; L-J Guo; W Gao
Journal:  Herz       Date:  2016-10-06       Impact factor: 1.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.